Il Giornale di Vicenza: ASAlaser therapies? A winning move!

06 August 2016 - Corporate -

Pulled muscles and sprains, tendinitis, joint and lumbar traumas are among the most feared events for athletes taking part in the Olympic Games in Rio de Janeiro. The leading cutting-edge therapies by ASAlaser – Hilterapia® and MLS® - have proved to be a fully effective solution for successfully treating and resolving these pathologies caused by overuse or overload, allowing the best performance. All in a short time. Il Giornale di Vicenza also backs this opinion focusing, in view of the opening of the Olympics (5th August), on the value of the company's therapeutic solutions, already adopted by top sports teams.

 

You might also be interested in ...

See all articles

Press - 05/09/2025
On World Physical Therapy Day on 8th September, the Vicenza-based company concludes the first edition of its welfare initiative, launched in 2024 and implemented in collaboration with Fisiolab 8.14...
Press - 16/06/2025
“School never ends” for the Vicenza-based company that involves a first group of collaborators in a training course aimed at improving internal communication and operational flows, thanks to games...
Press - 20/05/2025
The events organised by the Vicenza-based company on the theme "The value of diversity", chosen as the leitmotif for 2025, continue. On the World Day for Cultural Diversity, personnel were involved...
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.
Training ASAlaser devices for Taiwanese customers
News - 10/09/2025
The initiative offered a concrete and inspirational journey, allowing participants to delve deeper into the potential of the patented MLS® and Hilterapia® technologies, with a particular focus on the...
Press - 05/09/2025
On World Physical Therapy Day on 8th September, the Vicenza-based company concludes the first edition of its welfare initiative, launched in 2024 and implemented in collaboration with Fisiolab 8.14...